Document Detail


Antiplatelet agents in stroke prevention: acute and long-term treatment strategies.
MedLine Citation:
PMID:  19882077     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
In primary prevention, aspirin reduces the risk of stroke but not of myocardial infarction in women while in men only the risk of myocardial infarction but not stroke could be significantly reduced. Only aspirin has been shown to be safe and effective in large randomized trials in the first 48 hours after ischemic stroke. Aspirin/dipyridamole and clopidogrel both reduce the risk of a combined cardiovascular outcome in long-term secondary prevention compared to aspirin alone. More potent antiplatelet drugs or combination of aspirin and clopidogrel prevent more ischemic events, but also lead to more bleeding complications. No benefit of oral anticoagulants could be shown in patients with non-cardioembolic stroke. In patients with atrial fibrillation oral anticoagulation is more effective than aspirin in stroke prevention. The choice between oral anticoagulants and aspirin in these patients depends on age and the individual risk factor profile. Patients with symptomatic intracranial stenosis have a higher risk of intracerebral bleeding with oral anticoagulation compared to high dose aspirin. Aspirin is the recommended treatment in stroke patients with a patent foramen ovale.
Authors:
R Weber; C Weimar; H-C Diener
Related Documents :
436137 - Complications of coronary arteriography: a follow-up report.
11232987 - A safe and effective regimen without heparin therapy after successful primary coronary ...
20142447 - Predictors of outcomes in medically treated patients with acute coronary syndromes afte...
1481537 - The role of ptca in acute myocardial infarction.
25227407 - Left ventricular diameter and risk stratification for sudden cardiac death.
16650907 - Intracoronary aqueous oxygen perfusion, performed 24 h after the onset of postinfarctio...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Hämostaseologie     Volume:  29     ISSN:  0720-9355     ISO Abbreviation:  Hamostaseologie     Publication Date:  2009 Nov 
Date Detail:
Created Date:  2009-11-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8204531     Medline TA:  Hamostaseologie     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  326-33     Citation Subset:  IM    
Affiliation:
Department of Neurology and Stroke Center, University Duisburg-Essen, Essen, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The role of serotonin in haemostasis.
Next Document:  Platelet monitoring for PCI.